Approval · Notice of Compliance 4462 · 1996
APO-INDAPAMIDE: Notice of Compliance 4462
Issued August 6, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4462
- Date
- August 6, 1996
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Diuretic, antihypertensive
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-INDAPAMIDE | 02223678 | Marketed |
Medicinal ingredients
- INDAPAMIDE HEMIHYDRATE 2.5 MG per TAB